Harnessing artificial intelligence to improve clinical trial design

Bin Zhang; Lu Zhang; Qiuying Chen; Zhe Jin; Shuyi Liu; Shuixing Zhang

doi:10.1038/s43856-023-00425-3

Communications Medicine (Dec 2023)

Harnessing artificial intelligence to improve clinical trial design

Bin Zhang,
Lu Zhang,
Qiuying Chen,
Zhe Jin,
Shuyi Liu,
Shuixing Zhang

Affiliations

Bin Zhang: The First Affiliated Hospital of Jinan University
Lu Zhang: The First Affiliated Hospital of Jinan University
Qiuying Chen: The First Affiliated Hospital of Jinan University
Zhe Jin: The First Affiliated Hospital of Jinan University
Shuyi Liu: The First Affiliated Hospital of Jinan University
Shuixing Zhang: The First Affiliated Hospital of Jinan University

DOI: https://doi.org/10.1038/s43856-023-00425-3
Journal volume & issue: Vol. 3, no. 1
pp. 1 – 3

Abstract

Read online

Artificial intelligence (AI) has unparalleled potential to unlock useful information from real-world data to innovate trial design. Here, we discuss how AI can be used to optimize clinical trial design and potentially boost the success rate of clinical trials.

Published in Communications Medicine

ISSN: 2730-664X (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine
Website: https://www.nature.com/commsmed/

About the journal